The DOI matches its Crossref record.
Inhibition of neuronal Ca2+ influx by gabapentin and subsequent reduction of neurotransmitter release from rat neocortical slices
Open accessAbstract
Cytosolic calcium ion concentrations ([Ca 2+]i) were measured in rat neocortical synaptosomes using fura‐2, and depolarization of synaptosomal membranes was induced by K+ (30 m M). The release of the endogenous excitatory amino acids glutamate and aspartate was evoked by K+ (50 m M) and determined by HPLC. The release of [3 H]‐noradrenaline from rat neocortical synaptosomes or slices was evoked by K+ (15 and 25 m M) and measured by liquid scintillation counting. Gabapentin produced a concentration‐dependent inhibition of the K+‐induced [Ca 2+]i increase in synaptosomes (IC 50=14 μ M; maximal inhibition by 36%). The inhibitory effect of gabapentin was abolished in the presence of the P/Q‐type Ca 2+ channel blocker ω‐agatoxin IVA, but not by the N‐type Ca 2+ channel antagonist ω‐conotoxin GVIA. Gabapentin (100 μ M) decreased the K+‐evoked release of endogenous aspartate and glutamate in neocortical slices by 16 and 18%, respectively. Gabapentin reduced the K+‐evoked [3 H]‐noradrenaline release in neocortical slices (IC 50=48 μ M; maximal inhibition of 46%) but not from synaptosomes. In the presence of the AMPA receptor antagonists 6‐cyano‐7‐nitroquinoxaline‐2,3‐dione (CNQX) and 2,3‐dioxo‐6‐nitro‐1,2,3,4‐tetrahydro[f]quinoxaline‐7‐sulphonamide (NBQX), gabapentin did not reduce [3 H]‐noradrenaline release. Gabapentin did, however, cause inhibition in the presence of the NMDA receptor antagonist DL‐(E)‐2‐amino‐4‐methyl‐5‐phosphono‐3‐pentanoic acid (CGP 37849). Gabapentin is concluded to reduce the depolarization‐induced [Ca 2+]i increase in excitatory amino acid nerve terminals by inhibiting P/Q‐type Ca 2+ channels; this decreased Ca 2+ influx subsequently attenuates K+‐evoked excitatory amino acid release. The latter effect leads to a reduced activation of AMPA receptors which contribute to K+‐evoked noradrenaline release from noradrenergic varicosities, resulting in an indirect inhibition of noradrenaline release. British Journal of Pharmacology (2000) 130, 900–906; doi:10.1038/sj.bjp.0703380
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The mechanisms of action of gabapentin and pregabalin
SILLS, G. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.11.003 · Cited by 671
Taylor, C. P., Angelotti, T., & Fauman, E. (2007) · Epilepsy Research · doi:10.1016/j.eplepsyres.2006.09.008 · Cited by 565
Gabapentin: pharmacology and its use in pain management
Rose, M. A., & Kam, P. C. A. (2002) · Anaesthesia · doi:10.1046/j.0003-2409.2001.02399.x · Cited by 535
Glutamatergic substrates of drug addiction and alcoholism
Gass, J. T., & Olive, M. F. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.06.039 · Cited by 484
Molecular and cellular mechanisms of pharmacoresistance in epilepsy
Remy, S., & Beck, H. (2006) · Brain · doi:10.1093/brain/awh682 · Cited by 406
Metadata
- Authors
- Fink, K., Meder, W., Dooley, D. J., & Göthert, M.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2000-06
- Volume
- 130
- Issue
- 4
- Pages
- 900-906
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2145661927
- Cited by
- 169
- References
- 0
- FWCI
- 3.80
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inhibition of neuronal Ca2+ influx by gabapentin and subsequent reduction of neurotransmitter release from rat neocortical slices. https://app.cochat.ai/papers/10.1038/sj.bjp.0703380
- The paper
- Fink, K., Meder, W., Dooley, D. J., & Göthert, M. (2000). Inhibition of neuronal Ca2+ influx by gabapentin and subsequent reduction of neurotransmitter release from rat neocortical slices. British Journal of Pharmacology. https://doi.org/10.1038/sj.bjp.0703380
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.